Clinical trials
Recruiting Neurocognitive Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sunnybrook Health Sciences Centre | 2 |
| Laval University | 1 |
| MapLight Therapeutics | 1 |
| Olivier Beauchet | 1 |
| St. Joseph's Healthcare Hamilton | 1 |
| University of Manitoba | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurocognitive Disorders | 7 |
| Alzheimer Disease | 3 |
| Cognitive Dysfunction | 3 |
| Dementia | 3 |
| Mental Disorders | 2 |
| Nervous System Diseases | 2 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Cognition Disorders | 1 |
| Confusion | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.